Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted ascending | Why surfaced |
|---|---|---|---|---|---|---|---|
| ZDLJSOTC | Orval Compute Software | $160M | $0.7M/d | 4 | covered | 38 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| GRRXPOTC | Hexor Cloud Software | $288M | $1.9M/d | 5 | covered | 39 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| LTWJTNYSE | Falcrest Compute Software | $393M | $1.6M/d | 3 | covered | 39 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| QPNWNASDAQ | Yarrow Platform Software | $560M | $1.2M/d | 6 | covered | 44 | Bookings disclosure expanded; consensus model still references the prior format. |
| PEERCNASDAQ | Ember Sciences Healthcare | $211M | $1.4M/d | 5 | covered | 45 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| BACRNASDAQ | Kestrel Systems Software | $87M | $0.1M/d | 6 | covered | 47 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| UCZNNASDAQ | Borvel Therapeutics Healthcare | $351M | $0.9M/d | 0 | no coverage | 75 | Bookings disclosure expanded; consensus model still references the prior format. |
| RUPMOTC | Ember Diagnostics Healthcare | $256M | $0.5M/d | 0 | no coverage | 78 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| DPUMCOTC | Penna Therapeutics Healthcare | $466M | $1.8M/d | 0 | no coverage | 79 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| NTUNAMEX | Ember Compute Software | $214M | $0.9M/d | 0 | no coverage | 80 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| WSGFOTC | Junos Bio Healthcare | $282M | $1.2M/d | 0 | no coverage | 80 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| SLCUBOTC | Lumar Insurance Financials | $66M | $0.4M/d | 0 | no coverage | 81 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| FGGFOTC | Ravell Systems Software | $40M | $0.2M/d | 0 | no coverage | 81 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| NDKEYAMEX | Conduit Financial Financials | $134M | $0.4M/d | 0 | no coverage | 83 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| TJKMNASDAQ | Ulmar Bio Healthcare | $461M | $2.0M/d | 0 | no coverage | 83 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| GQGVNYSE | Penna Bancshares Financials | $505M | $2.8M/d | 0 | no coverage | 83 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| OAKMNYSE | Oakmoor Bancshares Financials | $198M | $0.6M/d | 0 | no coverage | 84 | CRE concentration plus rate-cycle inflection, no analyst voice since 2024. |
| ZGYJAMEX | Tarne Trust Financials | $33M | $0.1M/d | 0 | no coverage | 84 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| ENGEAMEX | Ravell Health Healthcare | $124M | $0.5M/d | 0 | no coverage | 86 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| VNXTNASDAQ | Ulmar Cloud Software | $646M | $1.2M/d | 0 | no coverage | 86 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| SJRQFNYSE | Aldra Bancshares Financials | $140M | $0.7M/d | 0 | no coverage | 87 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| GLACOTC | Glacier Insurance Holdings Financials | $76M | $0.2M/d | 0 | no coverage | 89 | OTC listing, sub-$80M cap, combined ratio improvement not modeled anywhere. |
| FAQSOTC | Orval Cloud Software | $90M | $0.4M/d | 0 | no coverage | 89 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |